Prostate Cancer Detection Rates of Standard Transrectal Prostate Biopsy and MR-guided Fusion Transrectal Prostate Biopsy
Prostate Cancer
About this trial
This is an interventional diagnostic trial for Prostate Cancer focused on measuring multiparametric prostate magnetic resonance imaging, MR-US fusion, MR guided prostate biopsy, prostate cancer
Eligibility Criteria
Inclusion Criteria:
PSA level 2,5-10mg/dl Approving the transrectal prostate biopsy and mpMR NO contraindication for MR: glomerular filtration rate (GFR) >60ml/dk, no claustrophobia, no prosthesis or cardiac pacemaker which is not suitable for MR no contraindication for stopping antiaggregant or antithrombotic treatment. no history of previous prostate biopsy no diagnosis of prostate cancer or other malignancies
Exclusion Criteria:
- not approving the biopsy and MR imaging
- having prosthesis or cardiac pace maker not suitable for MR
- having contraindication for stopping antiaggregant or antithrombotic treatment.
- history of previous prostate biopsy
Sites / Locations
- Department of Urology, Ercieys University, Faculty Of Medicine,
Arms of the Study
Arm 1
Arm 2
Active Comparator
Other
fusion arm
Standard arm
Patients in this arm will be undertaken standard transrectal prostate biopsy and MR guided MR-US fusion prostate biopsy
Patients in this arm will be undertaken only standard transrectal prostate biopsy